|
|
|
|
|
Detail |
| hsa-miR-126 |
|
Unspecified |
MicroRNA signatures in human ovarian cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
Endogenous human microRNAs that suppress breast cancer metastasis. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
MicroRNA-126 regulates HOXA9 by binding to the homeobox. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.
|
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
The cell growth suppressor, mir-126, targets IRS-1. |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
MicroRNA-regulated pathways associated with endometriosis. |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|